APA

Harari D., Orr I., Rotkopf R., Baranzini S. E. & Schreiber G. (20160216). A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis. : Human molecular genetics.

Chicago

Harari Daniel, Orr Irit, Rotkopf Ron, Baranzini Sergio E and Schreiber Gideon. 20160216. A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis. : Human molecular genetics.

Harvard

Harari D., Orr I., Rotkopf R., Baranzini S. E. and Schreiber G. (20160216). A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis. : Human molecular genetics.

MLA

Harari Daniel, Orr Irit, Rotkopf Ron, Baranzini Sergio E and Schreiber Gideon. A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis. : Human molecular genetics. 20160216.